Is there a link between lung parenchyma lesions , BMI , CRP , D-dimer and acute pulmonary embolism in patients infected with COVID-19 ?

Date publication

août 2021

Journal

Cardiovascular & hematological disorders drug targets

Auteurs

Membres identifiés du Cancéropôle Est :
Dr HAMMAS Karima

Tous les auteurs :
Hamadé A, Jambert L, Tousch J, Feuerstein P, Hammas K, Degoul S, Bensalah N, Michel P, Lehn-Hogg M, Obringer G, Buschenrieder N, Nusbaum P, Barakat N, Talbot M, Stephan D, Woehl B

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/34387171

Résumé

Since the outbreak of the COVID-19 pandemic , increasing suggests that infected patients present a high incidence of venous thromboembolic events (VTE). The main objective of this retrospective study was to evaluate the prevalence of acute pulmonary embolism (PE) on pulmonary computer tomography angiograms (CTPA) in patients classified as COVID-19 infection. The second objective was to determine if there is a link between D-dimer levels, serum C-reactive protein (CRP ), body mass index (BMI) , the lung parenchyma lesions (LPL) and acute pulmonary embolism (PE) in these patients.

Mots clés

C- reactive protein; lung parenchyma lesions. , COVID-19; Pulmonary embolism; D-dimer; Body mass index

Référence

Cardiovasc Hematol Disord Drug Targets. 2021 Aug 11;: